- Apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression
-
Hye-Geum Kim, Bon-Hoon Koo, Seung Woo Lee, Eun-Jin Cheon
-
Yeungnam Univ J Med. 2019;36(3):249-253. Published online March 15, 2019
-
DOI: https://doi.org/10.12701/yujm.2019.00150
-
-
10,261
View
-
132
Download
-
2
Citations
-
 Abstract
 PDF
- There is considerable overlap in the clinical presentations of apathy and depression. However, differential diagnosis between apathy and other psychiatric conditions, including depression and dementia, is important. In this report, we present the case of a 67-year-old woman with a history of receiving selective serotonin reuptake inhibitor (SSRI) treatment for depression. Differential diagnosis between treatment-resistant depression and SSRI-induced apathy syndrome was required. The symptoms of her apathy syndrome were relieved after the discontinuation of SSRIs and the addition of olanzapine, methylphenidate, and modafinil. Furthermore, we briefly review related literature in this article.
-
Citations
Citations to this article as recorded by  - Apathy associated with antidepressant drugs: a systematic review
Vasilios G. Masdrakis, Manolis Markianos, David S. Baldwin
Acta Neuropsychiatrica.2023; : 1. CrossRef - Investigation of the efficiency of various antidepressant replacement regimens in the development of SSRI-induced apathy syndrome
V. E. Medvedev, R. A. Kardashyan, V. I. Frolova, A. M. Burno, S. V. Nekrasova, V. I. Salyntsev
Neurology, Neuropsychiatry, Psychosomatics.2020; 12(2): 48. CrossRef
|
E-Submission
Yeungnam University College of Medicine
